A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
PHASE2
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (...
Status
Active Not Recruiting
Location
The University of Arizona Cancer Center - North Campus /ID# 242219
A Study Evaluating the Safety and Efficacy of Venetoclax (GDC-0199) Plus Bendamustine + Rituximab (BR) in Comparison With BR or Venetoclax Plus Rituximab in Participants With Relapsed and Refractory Follicular Non-Hodgkin's Lymphoma (fNHL)
PHASE2
This open-label, international, multicenter study will investigate the safe...
A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax
PHASE1
The purpose of this research study is to test the safety and efficacy of a ...